This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Use of Olanzapine in Anorexia Nervosa

Michael Menaster, MD

Published: May 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Barbarich et al.1 report the potential benefits of olanzapinein treating anorexia nervosa. I disagree with their resultsand conclusions for the following reasons.The study’s small sample size of 17 patients, 12 of whomcompleted the study, could result in a type II error. That 71% ofpatients completed the study is not "noteworthy," as the authorsclaim’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Eating Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...